Daily Newsletter

21 September 2023

Daily Newsletter

21 September 2023

UChicago Medicine begins work on $815m cancer care and research facility

This 575,000ft2 facility will house 80 inpatient beds, 90 outpatient exam rooms, imaging and clinical trial spaces.

September 20 2023

The University of Chicago Medicine has begun an $815m project to construct the first standalone cancer care and research pavilion in the US state of Illinois.

This seven-storey, 575,000ft2 facility is designed to advance cancer care and research.

It will house 80 inpatient beds, 90 outpatient exam rooms, imaging and clinical trial spaces, and a range of support services for patients and families.

University of Chicago Health System president Tom Jackiewicz said: “This project represents our latest bold move to make an even bigger difference in cancer care and research.

“This new pavilion will advance scientific discovery so that we can find cures, shape the future of oncology care and treatment, and reduce the cancer burden in the communities that we serve.”

This project aims to address rising cancer rates, particularly on the South Side of Chicago, and improve access to innovative treatments and clinical trials for underrepresented populations.

The pavilion is expected to open in spring 2027 and create over 500 construction jobs with a focus on minority- and women-owned businesses.

UChicago Medicine comprehensive cancer centre director Kunle Odunsi said: “My colleagues and I are determined to make a bigger impact in the field of cancer through the work we do at this new facility.

“We will leverage our location on the University of Chicago campus and our 49-year status as a National Cancer Institute-designated Cancer Center and newest member of the prestigious National Comprehensive Cancer Network to answer cancer’s hardest questions, bring new therapies from discovery to patients, deliver the care our community needs and, ultimately, save lives.”

Medical robotics set to witness robust growth in the next decade

GlobalData expects every segment of the medical robotics market to grow over the next decade, driven by the demands of high-volume procedures. Per GlobalData forecasts, the surgical robotics market is expected to grow at a CAGR of 8% by 2030. Surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robot models will offer new surgical possibilities, such as micro-robots to address difficult-to-treat diseases.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close